IGKV1D-33 report

I. Expression across cell types

Insufficient scRNA-seq data for expression of IGKV1D-33 at single-cell level.

II. Expression across tissues

sc-RNAseq data

Insufficient scRNA-seq data for expression of IGKV1D-33 at tissue level.

III. Associated gene sets

GO_0006955Biological processimmune response
GO_0002250Biological processadaptive immune response
GO_0002377Biological processimmunoglobulin production
GO_0005615Cellular componentextracellular space
GO_0072562Cellular componentblood microparticle
GO_0070062Cellular componentextracellular exosome
GO_0019814Cellular componentimmunoglobulin complex
GO_0005576Cellular componentextracellular region
GO_0005886Cellular componentplasma membrane
GO_0003823Molecular functionantigen binding

IV. Literature review

[source]
Gene nameIGKV1D-33
Protein nameImmunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)
Synonyms
DescriptionFUNCTION: V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition . Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens . The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen . .

AccessionsENST00000390265.2
P01593